Ignite Creation Date:
2024-05-05 @ 10:43 PM
Last Modification Date:
2024-10-26 @ 10:23 AM
Study NCT ID:
NCT01177683
Status:
TERMINATED
Last Update Posted:
2023-10-06
First Post:
2010-08-05
Brief Title:
Bendamustine in Combination With Bortezomib and Pegylated Liposomal Doxorubicin for Multiple Myeloma
Sponsor:
Sherif Farag MB BS
Organization:
Hoosier Cancer Research Network
Organization Data
Organization:
Hoosier Cancer Research Network
Class:
OTHER
Study ID:
MM08-141
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Sherif Farag MB BS
Lead Sponsor Class:
OTHER
Responsible Party:
Sherif Farag MB BS
Responsible Party Title:
Sponsor-Investigator
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Hoosier Cancer Research Network
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Cephalon Inc | INDUSTRY |
| Hoosier Cancer Research Network | OTHER |